Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial

Summary

Randomized, double-blind, placebo-controlled study comparing formoterol-beclometason 12/200 mcg BID versus placebo to evaluate the clinical effect on coughing in patients with non-cystic fibrosis (non-CF) bronchiectasis, native to inhaled corticosteroid (ICS) therapy and no history of asthma or chronic obstructive pulmonary disease (COPD)

Timeline

Start

2019-01-29

Primary completion

2022-07-05

Completion

2022-07-05

Drugs

Indications